The latest closing stock price for Neurocrine Biosciences as of March 28, 2025 is 113.16.
An investor who bought $1,000 worth of Neurocrine Biosciences stock at the IPO in 1996 would have $8,053 today, roughly 8 times their original investment - a 7.89% compound annual growth rate over 29 years.
The all-time high Neurocrine Biosciences stock closing price was 153.29 on January 30, 2025.
The Neurocrine Biosciences 52-week high stock price is 157.98, which is 39.6% above the current share price.
The Neurocrine Biosciences 52-week low stock price is 105.17, which is 7.1% below the current share price.
The average Neurocrine Biosciences stock price for the last 52 weeks is 131.24.
An investor who bought $1,000 worth of Neurocrine Biosciences stock at the IPO in 1996 would have $8,053 today, roughly 8 times their original investment - a 7.89% compound annual growth rate over 29 years.
The all-time high Neurocrine Biosciences stock closing price was 153.29 on January 30, 2025.
The Neurocrine Biosciences 52-week high stock price is 157.98, which is 39.6% above the current share price.
The Neurocrine Biosciences 52-week low stock price is 105.17, which is 7.1% below the current share price.
The average Neurocrine Biosciences stock price for the last 52 weeks is 131.24.